LakeShore Biopharma Co (LakeShore Biopharma Co) Scaled Net Operating Assets : 0.47 (As of Sep. 2023)

View and export this data going back to 2023. Start your Free Trial

What is LakeShore Biopharma Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

LakeShore Biopharma Co's operating assets for the quarter that ended in Sep. 2023 was $185.17 Mil. LakeShore Biopharma Co's operating liabilities for the quarter that ended in Sep. 2023 was $68.51 Mil. LakeShore Biopharma Co's Total Assets for the quarter that ended in Mar. 2023 was $249.57 Mil. Therefore, LakeShore Biopharma Co's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2023 was 0.47.

LakeShore Biopharma Co Scaled Net Operating Assets Historical Data

The historical data trend for LakeShore Biopharma Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LakeShore Biopharma Co Scaled Net Operating Assets Chart

LakeShore Biopharma Co Annual Data

Trend

Mar21

Mar22

Mar23

Scaled Net Operating Assets

-0.76

-0.52

0.55

LakeShore Biopharma Co Semi-Annual Data
	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Scaled Net Operating Assets	Get a 7-Day Free Trial			-	-	-0.45	0.56	0.47

Competitive Comparison of LakeShore Biopharma Co's Scaled Net Operating Assets

For the Biotechnology subindustry, LakeShore Biopharma Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LakeShore Biopharma Co's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LakeShore Biopharma Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where LakeShore Biopharma Co's Scaled Net Operating Assets falls into.

LakeShore Biopharma Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

LakeShore Biopharma Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Mar. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Mar. 2023 )
=	(Operating Assets (A: Mar. 2023 )	-	Operating Liabilities (A: Mar. 2023 ))	/	Total Assets (A: Mar. 2022 )
=	(195.859	-	71.495)	/	227.241
=	0.55

where

	Operating Assets		(A: Mar. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	249.569	-	53.71
=	195.859

	Operating Liabilities		(A: Mar. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	143.856	-	43.556	-	28.805
=	71.495

LakeShore Biopharma Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Sep. 2023 )
=	(Operating Assets (Q: Sep. 2023 )	-	Operating Liabilities (Q: Sep. 2023 ))	/	Total Assets (Q: Mar. 2023 )
=	(185.173	-	68.512)	/	249.569
=	0.47

where

	Operating Assets		(Q: Sep. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	220.787	-	35.614
=	185.173

	Operating Liabilities		(Q: Sep. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	144.451	-	50.21	-	25.729
=	68.512

LakeShore Biopharma Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of LakeShore Biopharma Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

LakeShore Biopharma Co (LakeShore Biopharma Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LakeShore Biopharma Co Ltd (NAS:LSB) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

H6Z:Germany

Address

38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629

Website

https://www.yishengbio.com

YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminium-free lyophilized rabies vaccine that was launched in China. It has one operating segment, which is the development, production, marketing and sale of biopharmaceutical products.